Lucentis and Potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lucentis (ranibizumab) and Potassium (potassium). Common drug interactions include death among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Lucentis and Potassium. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

On Jul, 30, 2026

27 people who take Lucentis and Potassium together, and have interactions are studied.

Lucentis and Potassium drug interactions.

What are the common drug interactions of Lucentis and Potassium, by gender? *:

female:

Death
Anaemia (lack of blood)
Arthralgia (joint pain)
Asthenia (weakness)
Back pain
Bacterial infection
Blindness
Blood calcium increased
Confusional state
Constipation

male:

Death
Acute respiratory failure
Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Chronic kidney disease
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dizziness
Dizziness postural

What are the common drug interactions of Lucentis and Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Death
Acute respiratory failure
Confusional state
Constipation
Cough
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Fluid overload (too much fluid in the blood)
Hypoxia (low oxygen in tissues)
Ill-defined disorder

What are the existing conditions these people have? *

Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 8 people, 29.63%
High Blood Pressure: 7 people, 25.93%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 22.22%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 18.52%
Age-Related Macular Degeneration: 3 people, 11.11%
Stress And Anxiety: 2 people, 7.41%
Pneumonia: 2 people, 7.41%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 7.41%
Diabetes: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and Potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously